Contact: Amy Molnar John Wiley & Sons.

He adds: The seventh study, the approach have particular relevance to resource-poor countries around the world. .. Contact: Amy Molnar John Wiley & Sons,7th of once-daily anti-HIV drugs could of HIV treatment of HIV treatment were performed in a small study at the U.S. National Institutes of Health , the researchers have shown that it may be possible HIV infected patients with treatment where a simple, once-daily administration of anti-HIV drugs in pre-planned, 7-day-on, 7-day-off cycles. – This approach is officially known as short-cycle structured intermittent antiretroviral therapy or colloquially as the 7-7 approach known. – Our data suggest that the 7-7 approach, with well-chosen drug regimens used high in situations where patient compliance is could be a powerful and cost-effective tool in the treatment of HIV-infected individuals may be says study author Mark Dybul, of the National Institute of Allergy and Infectious Diseases , a component of NIH.

Published in the 15th June 2006 issue of Cancer, a peer-reviewed journal of the American Cancer Society shows, the study found that external radiation therapy is as effective in younger patients with prostate cancer, as in older patients with the same stage is localized disease. The study is the first to investigate the outcome of radiation in men under 55 years.. Thereforen with prostate cancer Benefit From Radiation TherapyFor men under the age of 55 with localized prostate cancer, external beam radiation therapy can be an effective alternative to conservative and more invasive treatments, according to a new study.HIVMA specialists hand for interviews on access to supplies and other HIV / AIDS problem. Check by Steve Baragona of 299-0412 an interview an interview.

We find tragic is that in the richest country World, so many are not always the cultivation strongly urgently. .. On this World AIDS Day, December one woman in five with HIV in the USA has no health insurance. Half the estimated 460,000 men and women that need life-saving anti-retroviral drugs are not always, according to a recent report by Institute of Medicine of the National Academy of Sciences. These numbers are alarming, said Paul Volberding, chairman of the HIV Medicine Association Board of Directors and a member of the IOM panel which wrote the report.

Published by